After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...
In a trial of people with early Huntington's, the newly developed therapy slowed the progression of symptoms by 75%. reading time 3 minutes Doctors in the UK are claiming to have performed a ...
As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL ...
A one-time experimental treatment shows unprecedented success in slowing Huntington's disease, according to UCL researchers. FDA review expected in 2026.
The neurodegenerative disease damages patients’ motor, cognitive and behavioral controls, which sometimes manifest as ...
TAMPA, Fla. (WFLA) — For the first time, scientists have successfully treated someone suffering from Huntington’s disease, a fatal genetic illness with no cure. The Mayo Clinic reports that the ...
UniQure's UQ1.F experimental gene therapy for Huntington's disease slowed progression of the brain disorder by 75% in an early-to-mid stage study, it said on Wednesday. Huntington's is a rare ...
An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” Phase 1/2 study, according to drugmaker uniQure, marking a major step toward a potential first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback